Thunder Biotech

Thunder Biotech, Inc. is a privately held company based in Provo, Utah. With two employees, the company has generated $3 million in revenue. Thunder Biotech is a biotechnology company developing a novel cancer treatment called MOTO-CAR™ technology. This technology involves genetically engineered CAR macrophages that are designed to help a patient's immune cells recognize and attack solid tumors. MOTO-CAR™s are designed to be a more effective and less invasive alternative to traditional cancer treatments like surgery, radiation, and chemotherapy. The technology works by re-educating Tumor Associated Macrophages and restoring their ability to recognize and eliminate tumor cells. MOTO-CAR™s are also equipped with tumor-specific receptors that directly adhere to the tumor cell surface, initiating tumor cell destruction and recruiting the natural T cell response. For more information, visit Thunder Biotech's website at thunderbio.com.